A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Ganglioside GD1a Antibody (IgG), EIA
Test Code38916
Preferred Specimen
1 mL serum
Patient Preparation
Overnite fasting is preferred
Minimum Volume
0.2 mL
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 30 Days
Refrigerated: 7 days
Frozen: 30 Days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received room temperature
Methodology
Enzyme Immunoassay (EIA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon, Wed; Report available: 2 days
Clinical Significance
Ganglioside GD1a antibody IgG is associated with acute motor axonal neuropathy, sometimes followed by Campylobacter jejuni infections. Ganglioside GD1a antibody IgG can aid in the diagnosis of acute motor axonal neuropathy variant of Guillain-Barre syndrome.